Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Arogyavardhini Vati is an Ayurvedic hepatoprotective formula containing kutki, triphala, and shilajit that supports liver detoxification through enhanced bile production and antioxidant activity. The formula works by reducing hepatic oxidative stress and modulating liver enzyme levels, particularly ALT and AST.
Reported Benefits (Provisional)
Origin & History
Arogyavardhini Vati is a traditional Ayurvedic formulation consisting of multiple herbs and minerals, known for its detoxifying and liver-supportive properties.
Research Narrative (Provisional)
Research on Arogyavardhini Vati is limited, but some studies suggest its potential benefits for liver health and metabolic disorders. Further clinical trials are needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Arogyavardhini Vati is a classical Ayurvedic polyherbal-mineral formulation, not a food ingredient, so conventional macronutrient profiling does not apply. Its therapeutic profile is defined by its constituent bioactive compounds: (1) Parada (purified mercury, ~10-15% as per classical formulations) and Gandhaka (purified sulfur, ~10-15%), combined as Kajjali (black sulfide of mercury), which serve as the primary bio-enhancing matrix; (2) Loha Bhasma (iron ash, ~5-10%), contributing bioavailable ferrous iron supporting hematopoiesis; (3) Abhraka Bhasma (mica ash, ~5%), providing silica and trace minerals including magnesium and potassium; (4) Tamra Bhasma (copper ash, ~2-5%), supplying trace copper supporting enzymatic activity; (5) Triphala complex (Haritaki, Bibhitaki, Amalaki, ~15-20% combined), contributing tannins (chebulinic acid, ellagic acid ~2-5 mg/g), vitamin C (from Amalaki, ~400-600 mg/100g raw equivalent), and polyphenols; (6) Shilajatu (purified asphaltum, ~5-10%), providing fulvic acid (~15-20%), dibenzo-alpha-pyrones, and over 85 trace minerals; (7) Guggulu (Commiphora mukul resin, ~10-15%), supplying guggulsterones Z and E (~2-5% of resin), responsible for lipid-modulating effects; (8) Kutki (Picrorhiza kurroa, ~5-10%), providing picroside I and II (~2-4%), iridoid glycosides with hepatoprotective activity; (9) Chitrak (Plumbago zeylanica, ~3-5%), contributing plumbagin (~0.5-1%), a naphthoquinone with digestive-stimulant properties; (10) Neem (Azadirachta indica, ~3-5%), providing nimbidin and azadirachtin (~0.1-0.3%) with antimicrobial and skin-purifying actions. Bioavailability notes: Bhasma (metal ash) forms have nano-sized particles (50-500 nm), significantly enhancing bioavailability of minerals compared to inorganic salts; Kajjali undergoes extensive purification (shodhana) reducing free mercury to trace levels, though exact residual concentrations vary by manufacturer (WHO safety data limited). Fat-soluble bioactives like guggulsterones have moderate oral bioavailability (~20-30%), enhanced by the formulation's lipophilic matrix. Fiber content is negligible (<1%); protein is absent; carbohydrates are minimal (<5% from excipients). This formulation is standardized by therapeutic activity rather than nutritional content.
Reported Mechanism (Provisional)
Arogyavardhini Vati works through multiple pathways involving its key compounds including kutkin from kutki, tannins from triphala, and fulvic acid from shilajit. These bioactives enhance hepatic glutathione peroxidase and superoxide dismutase activity while inhibiting lipid peroxidation. The formula also stimulates bile acid synthesis through upregulation of cholesterol 7α-hydroxylase enzyme.
Clinical Narrative (Provisional)
Limited clinical studies have evaluated Arogyavardhini Vati, primarily small-scale trials with 30-60 participants over 8-12 week periods. Studies show significant reductions in liver enzymes (ALT/AST) by 25-40% and improvements in lipid profiles with LDL cholesterol decreasing by up to 20%. However, most research lacks placebo controls and larger sample sizes. Evidence quality remains moderate due to methodological limitations in available studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.